Rising CEA After Resection of Tubulovillous Adenoma with High-Grade Dysplasia
In a patient who underwent right hemicolectomy for a tubulovillous adenoma with high-grade dysplasia (but no invasive carcinoma), a rising CEA should NOT trigger surveillance protocols for invasive colorectal cancer, as CEA monitoring is only indicated for patients with stage II or III invasive carcinoma. 1
Why CEA Monitoring Doesn't Apply Here
The ASCO guidelines are explicit: postoperative CEA testing every 3 months is recommended only for patients with stage II or III invasive colorectal carcinoma 1. Your patient had high-grade dysplasia without invasive carcinoma—this is a pre-malignant lesion, not cancer. The guidelines do not support routine CEA monitoring in this population.
Key Distinction
- High-grade dysplasia = pre-cancerous change within the adenoma
- Invasive carcinoma = cancer that has breached the basement membrane
Since no invasive cancer was present, CEA surveillance protocols don't apply.
Explaining the Rising CEA: Benign Causes to Consider
If CEA was measured and found to be rising, consider these benign etiologies:
1. Benign Hepatobiliary Disease (Most Common)
- Chronic liver disease causes elevated CEA in >50% of cases, particularly:
- Active alcoholic cirrhosis
- Chronic active hepatitis
- Viral hepatitis
- Biliary cirrhosis 2
- Cholecystitis and biliary obstruction can elevate CEA, especially with concurrent cholangitis 2, 3
- The liver is essential for CEA metabolism/excretion—any hepatic dysfunction can cause elevation 2
Clinical Action: Check liver function tests, hepatitis panel, right upper quadrant ultrasound
2. Inflammatory Bowel Conditions
- Active ulcerative colitis correlates with disease severity and extent 2
- Pancreatitis (especially in smokers) 2
3. Smoking Status
- Smoking independently elevates CEA and compounds elevation from other causes 2
4. Transient Biological Fluctuations
- CEA can rise transiently without malignancy—documented in 9 of 25 patients meeting "significant rise" criteria in one series 4
- These transient rises often begin earlier postoperatively and may not follow exponential patterns 4
5. Rare: Idiopathic Persistent Elevation
- Case reports document markedly elevated CEA (>300 ng/mL) persisting for years without identifiable malignancy 5
Critical Pitfall to Avoid
Do not initiate cancer surveillance protocols or systemic therapy based on CEA elevation alone in this patient. The ASCO guidelines explicitly state that elevated CEA "by itself does not justify systemic therapy for presumed metastatic disease" even in patients WITH invasive cancer 1. This caution applies even more strongly to your patient without invasive disease.
Recommended Approach
Confirm the CEA elevation with repeat testing to rule out laboratory variation 4
Evaluate for benign causes systematically:
- Liver function tests and hepatobiliary imaging
- Smoking history
- Inflammatory conditions (IBD symptoms, pancreatitis)
- Review medications and recent procedures
If persistently elevated without benign explanation: Consider colonoscopy to evaluate for new adenomas or missed synchronous lesions, but recognize that the original pathology showed no invasive cancer
Avoid psychological harm: Inappropriate CEA testing in patients without invasive cancer causes unnecessary anxiety and diagnostic cascades 3, 6
Bottom Line
CEA was never indicated for monitoring in this patient. The elevation likely reflects benign hepatobiliary disease, inflammation, or smoking rather than occult malignancy. Focus on identifying and treating benign causes rather than pursuing cancer surveillance protocols designed for invasive disease.